Aharon Schwartz
Chairman at BIOLINERX LTD.
Net worth: 380 011 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zeev Bronfeld | M | 71 |
Protalix Ltd.
| 28 years |
| Eyal Rubin | M | 48 | 5 years | |
| Raf Hofstein | M | 74 |
Weizmann Institute of Science
| 27 years |
| Shmuel Ben Zvi | M | 64 | 13 years | |
| Amir Elstein | M | 67 | 29 years | |
| David Granot | M | 77 |
Protalix Ltd.
| - |
| Philip Serlin | M | 63 | 15 years | |
| Mark Sabag | M | 53 | 18 years | |
| Dror Bashan | M | 57 | 5 years | |
| Ella Sorani | M | 56 | 24 years | |
| Yael Ashman | M | - | 15 years | |
| Mutya Harsch | F | 50 |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Rami Dar | M | 67 | 2 years | |
| Annie Sabbah | M | - |
Barcode Diagnostics Ltd.
 Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | 7 years |
| Avi Schroeder | M | - |
Barcode Diagnostics Ltd.
Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | 7 years |
| Ronen Eavri | M | - |
Barcode Diagnostics Ltd.
Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | 7 years |
| John Lacey | M | - | - | |
| Gwen Melincoff | M | 72 | 5 years | |
| Asaf Aloni | M | - | - | |
| Pol Boudes | M | 67 | 5 years | |
| Prasad Vanga | M | - |
Anthill Ventures
 Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 9 years |
| Yosi Ben-Dov | M | - |
The Hebrew University of Jerusalem
| 10 years |
| Yaron Naos | M | 60 | 20 years | |
| Barbara-Jean Bormann-Kennedy | M | 65 | 11 years | |
| Eliot Forster | M | 58 | 1 years | |
| Amos Bar Shalev | M | 71 | 16 years | |
| Avraham Molcho | M | 66 | 14 years | |
| Tzvi Palash | M | 67 |
Protalix Ltd.
| 14 years |
| Jonathan Burgin | M | 63 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| Sandra Panem | M | 77 | 10 years | |
| Gina Balderas | F | - | - | |
| Varun A G Reddy | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 4 years |
| Vikki Conway | F | - | 14 years | |
| Tali Yaron Dalah | F | 46 | - | |
| Gaurav Verliani | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 4 years |
| Rajeev Menon | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 9 years |
| Jaswanth Varma | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 6 years |
| Zaran Bhagwagar | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 6 years |
| Amlan Baijal | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | - |
| Ofir Elyasaph Madmon | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | - |
| Ilan Kremer | M | 57 |
The Hebrew University of Jerusalem
| 13 years |
| Sailesh Sigatapu | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 9 years |
| Devang Mehta | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | - |
| Eyal Sheratzky | M | 56 |
Protalix Ltd.
| - |
| Sameer Ganapathy | M | - |
Anthill Ventures
Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leeat Bar-Eyal | M | - |
The Hebrew University of Jerusalem
| 9 years |
| Yossi Maimon | M | 53 | 13 years | |
| Avraham Hochberg | M | 86 |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 years |
| Meir Eini | M | 69 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 14 years |
| Ofra Yamin | F | 61 | 20 years | |
| Moshe Manor | M | 67 | 34 years | |
| Udi Gilboa | M | 57 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | 6 years |
| David Leibler | M | - |
The Hebrew University of Jerusalem
| 10 years |
| Dov Tamarkin | M | 68 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 15 years |
| Erez Israeli | M | 57 | - | |
| Howard Rosen | M | 66 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | 4 years |
| David Domzalski | M | 58 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| David Baker | M | 60 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | 3 years |
| Shlomo Yanai | M | 71 | 12 years | |
| Eyal Desheh | M | 72 | 9 years | |
| David Aviezer | M | 59 | 8 years | |
| Yoseph Shaaltiel | M | 71 | 27 years | |
| Richard S. Egosi | M | 61 | 21 years | |
| Erez Vigodman | M | 64 | 8 years | |
| Nurit Benjamini | F | 57 | - | |
| Abi Vainstein-Haras | M | 49 | 7 years | |
| Maya Michelsohn | F | - | 8 years | |
| Dana Bublil | F | - |
The Hebrew University of Jerusalem
| 6 years |
| Nir Falevich | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Alon Greenspan | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Guy Yavin | M | - |
The Hebrew University of Jerusalem
| 5 years |
| Josh Hersch | M | - |
The Hebrew University of Jerusalem
| 5 years |
| Bentzi Rabi | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Craig Marshall Lea | M | 71 | 16 years | |
| Eli Shani | M | - | - | |
| Sheli Saban | F | 42 |
The Hebrew University of Jerusalem
| 9 years |
| Itamar Ophel | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Zohar Nevo | M | - |
The Hebrew University of Jerusalem
| 2 years |
| Inbar Weiss | M | - |
The Hebrew University of Jerusalem
| 7 years |
| David M. Stark | M | 55 | 21 years | |
| Phillip Frost | M | 87 | 9 years | |
| Zviel Gedalihou | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Joseph Nitzani | M | 77 | - | |
| Morris Laster | M | 60 | 6 years | |
| William S. Marth | M | 69 | 2 years | |
| Joao Siffert | M | 60 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | - |
| Roger Abravanel | M | 77 | 10 years | |
| Leora Meridor | M | 76 | 9 years | |
| Yodfat Harel Gross Buchris | F | 52 | 11 years | |
| Ory Slonim | M | 80 | - | |
| Felicia Ladin | F | 52 | 6 years | |
| Isaac Abravanel | M | 70 | 7 years | |
| Chaim Hurvitz | M | 63 | 15 years | |
| Sven Dethlefs | M | 55 | 15 years | |
| Arieh Ben-Yosef | M | 71 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | 3 years |
| Raul Chertkoff | M | - | - | |
| Joshua Levine | M | 59 | 5 years | |
| Tomer Berkovitz | M | 44 |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | 4 years |
| Hadas Peker-Nir | F | - |
The Hebrew University of Jerusalem
| 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 73 | 73.74% |
| United States | 21 | 21.21% |
| India | 11 | 11.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Aharon Schwartz
- Personal Network
